These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21903562)

  • 1. FDA new drug approvals in 2010.
    Wynn RL
    Gen Dent; 2011; 59(4):250-3. PubMed ID: 21903562
    [No Abstract]   [Full Text] [Related]  

  • 2. New drugs: Liraglutide, dalfampridine, and abobotulinumtoxinA.
    Hussar DA; Kaczinski J
    J Am Pharm Assoc (2003); 2010; 50(3):436-9. PubMed ID: 20452924
    [No Abstract]   [Full Text] [Related]  

  • 3. Significant FDA approvals in 1999.
    McGinnis TJ
    Am Fam Physician; 2000 Apr; 61(8):2531-3. PubMed ID: 10794586
    [No Abstract]   [Full Text] [Related]  

  • 4. New drugs and product approvals from 2001.
    Taylor SE
    Tex Dent J; 2002 Dec; 119(12):1186-98. PubMed ID: 12592740
    [No Abstract]   [Full Text] [Related]  

  • 5. New drug approvals in 2001.
    Wynn RL
    Gen Dent; 2002; 50(4):304-8, 310. PubMed ID: 12640845
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA approves new treatment for late-onset Pompe disease.
    Home Healthc Nurse; 2010 Sep; 28(8):457. PubMed ID: 20811179
    [No Abstract]   [Full Text] [Related]  

  • 7. 10 questions about 4-aminopyridine and the treatment of multiple sclerosis.
    Bever CT
    Neurologist; 2009 May; 15(3):161-2. PubMed ID: 19430274
    [No Abstract]   [Full Text] [Related]  

  • 8. 4-Aminopyridine: new life for an old drug. Reply.
    Cohen R; Blight AR
    Ann Neurol; 2011 Jan; 69(1):218-20. PubMed ID: 21280101
    [No Abstract]   [Full Text] [Related]  

  • 9. 2011 FDA drug approvals.
    Mullard A
    Nat Rev Drug Discov; 2012 Feb; 11(2):91-4. PubMed ID: 22293555
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV approval for wrinkle filler.
    AIDS Patient Care STDS; 2007 Feb; 21(2):146-7. PubMed ID: 17370355
    [No Abstract]   [Full Text] [Related]  

  • 11. New drug approvals in 2000.
    Wynn RL
    Gen Dent; 2001; 49(4):341-5. PubMed ID: 12016673
    [No Abstract]   [Full Text] [Related]  

  • 12. 1992 FDA drug approvals.
    Wynn RL
    Gen Dent; 1993; 41(4):286-7. PubMed ID: 8262339
    [No Abstract]   [Full Text] [Related]  

  • 13. Something old, something new--colchicine in the 21st century.
    Cronstein BN
    Curr Opin Investig Drugs; 2009 Nov; 10(11):1141-2. PubMed ID: 19876781
    [No Abstract]   [Full Text] [Related]  

  • 14. EMEA approves OGS drug rejected by FDA.
    Mitchell P
    Nat Biotechnol; 2002 Sep; 20(9):858-9. PubMed ID: 12205490
    [No Abstract]   [Full Text] [Related]  

  • 15. StatBite. FDA-required postmarketing studies, 1992-2008.
    J Natl Cancer Inst; 2010 Sep; 102(17):1303. PubMed ID: 20739654
    [No Abstract]   [Full Text] [Related]  

  • 16. New drug approvals in 1999.
    Wynn RL
    Gen Dent; 2000; 48(4):380-4. PubMed ID: 11199608
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA notifications. New guidance assists HIV drug development. Changes affect approvals for antiretroviral drugs.
    AIDS Alert; 2003 Jan; 18(1):10-1. PubMed ID: 12541998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing tumor-related signs and symptoms to support cancer drug approval.
    Williams G; Pazdur R; Temple R
    J Biopharm Stat; 2004 Feb; 14(1):5-21. PubMed ID: 15027497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA approvals and label changes.
    AIDS Patient Care STDS; 2009 Jul; 23(7):578-9. PubMed ID: 19621996
    [No Abstract]   [Full Text] [Related]  

  • 20. New drug approvals in 2002.
    Wynn RL
    Gen Dent; 2003; 51(3):212-6. PubMed ID: 15055702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.